Fradet Y - Search Results

1

Radical cystectomy for the treatment of T1 bladder cancer: the Canadian Bladder Cancer Network experience.

Chalasani V, Kassouf W, Chin JL, Fradet Y, Aprikian AG, Fairey AS, Estey E, Lacombe L, Rendon R, Bell D, Cagiannos I, Drachenberg D, Lattouf JB, Izawa JI. Chalasani V, et al. Among authors: fradet y. Can Urol Assoc J. 2011 Apr;5(2):83-7. doi: 10.5489/cuaj.10040. Can Urol Assoc J. 2011. PMID: 21470529 Free PMC article.

2

[Clinical value of the study of proliferation and cell activation antigens with flow cytometry in bladder cancer].

Lacombe L, Gauthier J, Lafleur L, Fradet Y. Lacombe L, et al. Among authors: fradet y. Prog Urol. 1996 Dec;6(6):907-12. Prog Urol. 1996. PMID: 9235176 French.

3

CUOG randomized trial of neoadjuvant androgen ablation before radical prostatectomy: 36-month post-treatment PSA results. Canadian Urologic Oncology Group.

Klotz LH, Goldenberg SL, Jewett M, Barkin J, Chetner M, Fradet Y, Chin J, Laplante S. Klotz LH, et al. Among authors: fradet y. Urology. 1999 Apr;53(4):757-63. doi: 10.1016/s0090-4295(98)00616-5. Urology. 1999. PMID: 10197852 Clinical Trial.

4

Can biological markers predict recurrence and progression of superficial bladder cancer?

Fradet Y, Lacombe L. Fradet Y, et al. Curr Opin Urol. 2000 Sep;10(5):441-5. doi: 10.1097/00042307-200009000-00013. Curr Opin Urol. 2000. PMID: 11005449 Review.

5

Blood management and radical retropubic prostatectomy: Quebec experience.

Lacombe L, Fradet Y. Lacombe L, et al. Among authors: fradet y. Can J Urol. 1999 Apr;6(2):727-731. Can J Urol. 1999. PMID: 11178596

6

Expression of p21 predicts PSA failure in locally advanced prostate cancer treated by prostatectomy.

Lacombe L, Maillette A, Meyer F, Veilleux C, Moore L, Fradet Y. Lacombe L, et al. Among authors: fradet y. Int J Cancer. 2001 May 20;95(3):135-9. doi: 10.1002/1097-0215(20010520)95:3<135::aid-ijc1023>3.0.co;2-3. Int J Cancer. 2001. PMID: 11307144

7

Duration of neoadjuvant androgen deprivation therapy before radical prostatectomy and disease-free survival in men with prostate cancer.

Meyer F, Bairati I, Bédard C, Lacombe L, Têtu B, Fradet Y. Meyer F, et al. Among authors: fradet y. Urology. 2001 Aug;58(2 Suppl 1):71-7. doi: 10.1016/s0090-4295(01)01245-6. Urology. 2001. PMID: 11502453

8

Neoadjuvant hormone therapy before salvage radiotherapy for an increasing post-radical prostatectomy serum prostate specific antigen level.

Tiguert R, Rigaud J, Lacombe L, Laverdière J, Fradet Y. Tiguert R, et al. Among authors: fradet y. J Urol. 2003 Aug;170(2 Pt 1):447-50. doi: 10.1097/01.ju.0000075351.51838.b3. J Urol. 2003. PMID: 12853796

9

Routine nasogastric tubes are not required following cystectomy with urinary diversion: a comparative analysis of 430 patients.

Inman BA, Harel F, Tiguert R, Lacombe L, Fradet Y. Inman BA, et al. Among authors: fradet y. J Urol. 2003 Nov;170(5):1888-91. doi: 10.1097/01.ju.0000092500.68655.48. J Urol. 2003. PMID: 14532800

10

Insomnia in men treated with radical prostatectomy for prostate cancer.

Savard J, Simard S, Hervouet S, Ivers H, Lacombe L, Fradet Y. Savard J, et al. Among authors: fradet y. Psychooncology. 2005 Feb;14(2):147-56. doi: 10.1002/pon.830. Psychooncology. 2005. PMID: 15386779

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

351 results

Search Page

Filters